Nucleate Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Professionals
-
13
- Investments
-
122
- Portfolio
-
100
- Exits
-
11
Nucleate General Information
Company Description
Founded in 2019, Nucleate is an accelerator firm based in Brighton, Massachusetts. The firm focuses on biotech and life sciences companies.
Business Details
Website
nucleate.orgYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 88 Gordon Street
- Suite 401
- Brighton, MA 02135
- United States
Nucleate Investments (122)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Sebastian BioPharma | 25-Mar-2026 | Accelerator/Incubator | Drug Discovery | Pre-Clinical Trials | ||
| Dandelion Diagnostics | 01-Jan-2026 | Biotechnology | Generating Revenue | |||
| Fervid | 01-Jan-2026 | Drug Delivery | Pre-Clinical Trials | |||
| KonsciousPlanet | 01-Jan-2026 | Other Chemicals and Gases | Generating Revenue | |||
| Lucier | 01-Jan-2026 | Drug Discovery | Pre-Clinical Trials | |||
| AmyGo Solutions | 06-Aug-2025 | Biotechnology | Startup | |||
| BioDelivera | 30-May-2025 | Biotechnology | Startup | |||
| Braiv (Decision/Risk Analysis) | 15-May-2025 | Decision/Risk Analysis | Generating Revenue | |||
| Sereneuro Therapeutics | 14-May-2025 | Accelerator/Incubator | Drug Discovery | Pre-Clinical Trials | ||
| NeXendia | 25-Apr-2025 | Accelerator/Incubator | Laboratory Services (Healthcare) | Startup |
Nucleate Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ivu Biologics | 17-Jan-2026 | Out of Business | |
| Hybridex Biosciences | 01-Oct-2025 | ||
| NextRNA | 01-Aug-2025 | ||
| OrganOmics | 20-Jun-2025 | ||
| MyoArete | 18-Sep-2024 | ||
| Pulseflex | 04-May-2024 | ||
| Kumuda | 29-Dec-2023 | ||
| PionEar Technologies | 29-Dec-2023 | ||
| Lymphagen | 17-Oct-2023 | Out of Business | |
| Beacon Bio | 10-Jun-2021 | Merger/Acquisition |
Nucleate Investments by Industry, Year, and Region
Nucleate Co-Investors (15)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Pillar VC | 3 |
|
|
||
| BlueYard Capital |
|
|
|||
| Alnylam Pharmaceuticals |
|
|
|||
| Cambridge Enterprise Ventures |
|
|
|||
| Right Side Capital Management |
|
|
Nucleate FAQs
-
What is Nucleate?
Founded in 2019, Nucleate is an accelerator firm based in Brighton, Massachusetts.
-
When was Nucleate founded?
Nucleate was founded in 2019.
-
Where is Nucleate headquartered?
Nucleate is headquartered in Brighton, MA.
-
How many investments has Nucleate made?
Nucleate has made 122 investments.
-
What has Nucleate invested in?
Nucleate has made numerous investments in companies like Sebastian BioPharma, Dandelion Diagnostics, and Fervid within the Drug Discovery, Biotechnology, and Drug Delivery industries.
-
What has Nucleate invested in recently?
Nucleate's latest investment was on 25-Mar-2026 in Sebastian BioPharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process